-
Product Insights
Higashi Nasu Solar PV Park
Higashi Nasu Solar PV Park is a solar PV project located in Tochigi, Japan. The project is owned and developed by Invenergy Japan GK. The project is currently under construction. Empower your strategies with our Higashi Nasu Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Renova-Nasu Karasuyama Solar PV Park
Renova-Nasu Karasuyama Solar PV Park is a solar PV project located in Tochigi, Japan. The project is owned and developed by Renova Inc. The project came online in 2019. Empower your strategies with our Renova-Nasu Karasuyama Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
LS Nasu Nakagawa Solar PV Park
LS Nasu Nakagawa Solar PV Park is a solar PV project located in Tochigi, Japan. The project was developed by Mirarth Holdings Inc. The project came online in 2016. Empower your strategies with our LS Nasu Nakagawa Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QN-023a in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QN-023a in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QN-023a in Relapsed Acute Myeloid Leukemia Drug Details: QN-023a is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bintrafusp Alfa in Thymic Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bintrafusp Alfa in Thymic Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bintrafusp Alfa in Thymic Carcinoma Drug Details: Bintrafusp alfa is...
-
Product Insights
Emesis (Vomiting) – Drugs In Development, 2023
Global Markets Direct’s, ‘Emesis (Vomiting) - Drugs In Development, 2023’, provides an overview of the Emesis (Vomiting) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Emesis (Vomiting), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Anaphylaxis – Drugs In Development, 2023
Global Markets Direct’s, ‘Anaphylaxis - Drugs In Development, 2023’, provides an overview of the Anaphylaxis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Acute Opioid Overdosage – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Opioid Overdosage - Drugs In Development, 2023’, provides an overview of the Acute Opioid Overdosage pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Seasonal Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Seasonal Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Seasonal Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Seizures – Drugs In Development, 2023
Global Markets Direct’s, ‘Seizures - Drugs In Development, 2023’, provides an overview of the Seizures pipeline landscape. The report provides comprehensive information on the therapeutics under development for Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...